Danilo Segovia

EDUCATION

B.S. Biology, Universidad de la República (Uruguay), 2014

M.S. Biology Universidad de la República (Uruguay), 2016

SUMMARY

Danilo received his B.S and M.S. in Biology from the Universidad de la República (Uruguay). During his undergraduate studies, he worked on p53 synonymous mutations and their role in  cancer, and during his master studies, he performed structural studies on the Orf virus tyrosine phosphatase OH1. Danilo then started his PhD studies in the Molecular & Cellular Biology program at Stony Brook University. He joined the Krainer lab, where he is focused on exploring the SRSF1 protein interactome in the context of pre mRNA splicing. Danilo enjoys playing clarinet in his free time. 

PUBLICATIONS

Safaric Tepes, P., Segovia, D., Jevtic, S., Ramirez, D., Lyons, S. K., & Sordella, R. (2022). Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-NCoA2-driven mesenchymal chondrosarcoma. Lab Invest. , 102(9), 1038–1049.

Segovia, D., Haouz, A., Porley, D., Olivero, N., Martínez, M., Mariadassou, M., Berois, M., André-Leroux, G., & Villarino, A. (2017). OH1 from Orf Virus: A New Tyrosine Phosphatase that Displays Distinct Structural Features and Triple Substrate Specificity. J. of Mol. Bio., 429(18), 2816–2824.